GenoType MRSA
The basic test for culture confirmation
Our GenoType MRSA test system enables precise genetic identification of S. aureus and S. epidermidis from cultures, ensuring accurate differentiation of clinically significant pathogens causing staphylococcal infections.
Since S. aureus exhibits particularly high pathogenicity, its reliable detection is crucial for the introduction of targeted treatment and hygiene measures. In addition, the mecA and mecC genes that impart methicillin resistance as well as a specific fragment of the PVL gene are simultaneously detected with the GenoType MRSA.
The presence of PVL gives an indication of CA-MRSA strains acquired in the environment. In contrast to nosocomial MRSA, CA-MRSA have a higher pathogenicity, but do not demonstrate any multiresistance to antibiotics. Therefore, distinguishing CA-MRSA from nosocomial MRSA is crucial for therapeutic and epidemiological viewpoint.
GenoType MRSA thus serves as an optimal solution for cost-effective MRSA diagnostics, and reliable culture confirmation.
Benefits
Differentiability: Detecting S. aureus and S. epidermidis with only one test offers you the basis for a safe therapy and hygienic management.
High specificity: Simultaneous detection of the resistance mediating genes mecA and mecC as well as a PVL-specific fragment provide unambiguous results and reliable MRSA identification. A distinction between CA-MRSA and nosocomial infections is thus provided.
Rapid result: Performing the test from the overnight culture provides you with a result in only 4 hours and thus guarantees rapid diagnosis.
